Adverse Events in Total Artificial Heart for End-Stage Heart Failure: Insight From the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE)
Open Access
- 1 January 2024
- journal article
- research article
- Published by XMLink in International Journal of Heart Failure
- Vol. 6 (2) , 76-81
Abstract
Tan MC, et al. Int J Heart Fail. 2023 Sep;5:e23. https://doi.org/10.36628/ijhf.2023.0020Keywords
This publication has 28 references indexed in Scilit:
- Impact of INTERMACS Profile on Clinical Outcomes for Patients Supported With the Total Artificial HeartJournal of Cardiac Failure, 2016
- Matching the Market for Heart TransplantationCirculation: Heart Failure, 2016
- Results With Syncardia Total Artificial Heart Beyond 1 YearASAIO Journal, 2014
- Results with an Anticoagulation Protocol in 99 SynCardia Total Artificial Heart RecipientsASAIO Journal, 2013
- The challenge of home discharge with a total artificial heart: the La Pitié Salpêtrière experienceEuropean Journal of Cardio-Thoracic Surgery, 2013
- Experience with more than 100 total artificial heart implantsThe Journal of Thoracic and Cardiovascular Surgery, 2012
- INTERMACS Profiles of Advanced Heart Failure: The Current PictureThe Journal of Heart and Lung Transplantation, 2009
- CardioWest (Jarvik) Total Artificial Heart: A Single-Center Experience With 42 PatientsThe Annals of Thoracic Surgery, 2009
- Advanced Chronic Heart Failure: A Position Statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure, 2007
- CardioWest Total Artificial Heart: Bad Oeynhausen ExperienceThe Annals of Thoracic Surgery, 2005